Skip to main content

Fidelity Global Healthcare Fund

Fidelity Global Healthcare Fund is an equity fund managed by Fidelity in the Sektor – Helse category.

About this fund

Fidelity Global Healthcare Fund sits in the Sektor – Helse peer group, where Fidelity is the manager.

The fund: 26 years of track record, running since 2000 (share classes may be younger).

On return so far this year measured in NOK as of 13.11.2026, it places 16 of 18 funds in the group.

Tracking error against its benchmark is 4.3%.

The manager-stated volatility is 14.4%.

It is measured against MSCI ACWI Health Care Index (Net).

Manager
Fidelity
Category
Sektor – Helse
Region
Global
Sector
Health Care
Style
Sector Focus
SFDR
Article 8
ISIN
LU0261952419
Inception
2000-09-01
Benchmark
MSCI ACWI Health Care Index (Net)
AUM
1.2 bn EUR
Returns
YTD 1.5% · 1Y 2.5% · 3Y 1.4% · 5Y 2.5%

Portfolio managers

Actively managedEquityGlobalHealth care
YTD Return · NOK
+1,5 %from NAV
Calculated NOK return from EUR · A-ACC-EUR (NOK Calculated)

Computed from NAV history (to 13 Nov 2026)

Last NAV 71,66 EUR · 13 Nov 2026
Returns by period · NOK · net
ann. 3Y+
+1,5 %
YTD
+2,5 %
1y
+1,4 %
3y, annualised
+2,5 %
5y, annualised
+8,8 %
10y, annualised
Fund size
1,2 mrd. EUR
Total fund AUM
Management fee
1,50 %
Annual · class A-ACC-EUR
Ongoing charge
1,90 %
Annual · class A-ACC-EUR
Performance fee
None
Stated by the manager
Annual cost on platforms
1,30 %–1,45 %
Class A-EUR · 5 platforms · net of platform rebate, incl. platform fee, excl. transaction costs
SFDR
Article 8
Sustainability
Launched
Sept 2000
ISIN LU0114720955
BenchmarkMSCI ACWI Health Care · Net
Fund website
Risk
Volatility (stated by the manager)14,4 %
Sharpe Ratio0,15
Beta1,01
Info Ratio−1,54
Tracking Error4,3 %
About the fund
The fund

Fidelity Global Healthcare Fund is an actively managed health care fund with a track record back to 2000. The management company is Fidelity International, headquartered in London. It was established in 1969 as the international arm of the US-based Fidelity Investments and became independent in 1980. It is privately owned, mainly by management and members of the founding family.

Investment philosophy

The manager looks for companies that can compound steadily over time, driven by structural growth in health care from an ageing population and increased health care needs. He looks for three characteristics: quality, visibility and sustainability. Specifically, he seeks companies with high and sustainable return on invested capital (ROIC), and companies that can improve it. The portfolio is held within pharmaceuticals, biotechnology, medical devices and health insurance. The manager stresses that these companies are defensive, since demand for drugs and treatment holds up in turbulent times.

The managers

The fund is managed by Alex Gold in London, who has done so since 2017. He joined Fidelity in 2010 after experience at PricewaterhouseCoopers and is a chartered accountant (ACA). He also manages Fidelity Global Demographics Fund and Sustainable Global Health Care Fund.

The portfolio

The portfolio is concentrated, with fewer holdings than comparable funds, and consists almost entirely of large companies. Active share is below the median of comparable funds. The fund has fluctuated less than comparable funds. Lasting top holdings include Eli Lilly, Roche, AstraZeneca, Stryker, AbbVie, Thermo Fisher Scientific and Gilead Sciences.

FundTelligence description · 18/10/2026
Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

Portfolio managers

AL
Portfolio Manager
On the fund since Jul 1, 2017

Position in the peer group

Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.

7 of 18 funds ranked on a calculated return

#16/ 18Year to date
+1.49% NOK

as of 13 Nov 2026 · Converted from EUR to NOK

About the figures

13 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#19/ 221 year
+2.51% NOK

as of 13 Nov 2026 · Converted from EUR to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#22/ 223 years (ann.)
+1.36% NOK

as of 13 Nov 2026 · Converted from EUR to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#19/ 225 years (ann.)
+2.46% NOK

as of 13 Nov 2026 · Converted from EUR to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

Comparison basis

Year to date

Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

1 year

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

3 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

5 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data